RGDS is a classic adhesion motif interacting with integrin receptors and influencing cell-matrix communication. The short sequence promotes studies of β-turn formation, surface binding, and ligand-receptor docking. Researchers use it to probe extracellular-matrix interactions and receptor specificity. Its simplicity supports widespread biochemical and structural analyses.
CAT No: R1883
CAS No:91037-65-9
Synonyms/Alias:Arg-gly-asp-ser;91037-65-9;Rgds peptide;Fibronectin tetrapeptide;Arginyl-glycyl-aspartyl-serine;RGDS;UNII-AC6UDA2MFC;L-Arginylglycyl-L-alpha-aspartyl-L-serine;AC6UDA2MFC;MFCD00076452;CHEMBL265628;(3S)-3-[[2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-4-[[(1S)-1-carboxy-2-hydroxyethyl]amino]-4-oxobutanoic acid;L-Serine, N-(N-(N-L-arginylglycyl)-L-alpha-aspartyl)-;RGDS peptide; Fibronectin tetrapeptide;Arg-Gly-Asp-Ser?;Fibronectin Inhibitor;Arg-Gly-Asp-Ser peptide;H-Arg-Gly-Asp-Ser-OH;L-Serine, L-arginylglycyl-L-alpha-aspartyl-;SCHEMBL7394659;DTXSID50920002;Fibronectin Inhibitor Tetrapeptide;CHEBI:232857;NNRFRJQMBSBXGO-CIUDSAMLSA-N;BDBM50241180;DU-728;RGDS peptide;Fibronectin tetrapeptide;AKOS024457642;Arg-Gly-Asp-Ser, >=95% (HPLC);CS-3266;FR73590;NCGC00167153-01;(6S,12S,15S)-1,6-diamino-12-(carboxymethyl)-15-(hydroxymethyl)-1-imino-7,10,13-trioxo-2,8,11,14-tetraazahexadecan-16-oic acid;AS-56630;DA-61200;HY-12290;C77102;BRD-K08859203-001-01-9;L-SERINE, L-ARGINYLGLYCYL-L-.ALPHA.-ASPARTYL-;Q27273860;(3S)-3-{2-[(2S)-2-AMINO-5-CARBAMIMIDAMIDOPENTANAMIDO]ACETAMIDO}-3-{[(1S)-1-CARBOXY-2-HYDROXYETHYL]CARBAMOYL}PROPANOIC ACID;(6S,12S,15S)-1,6-diamino-12-(carboxymethyl)-16-hydroxy-1-imino-7,10,13-trioxo-2,8,11,14-tetraazahexadecane-15-carboxylic acid;(S)-3-[2-((S)-2-Amino-5-guanidino-pentanoylamino)-acetylamino]-N-((R)-1-carboxy-2-hydroxy-ethyl)-succinamic acid;(S)-3-[2-((S)-2-Amino-5-guanidino-pentanoylamino)-acetylamino]-N-((S)-1-carboxy-2-hydroxy-ethyl)-succinamic acid;2-[1-[1-amino-4-amino(imino)methylamino-(1S)-butylcarboxamidomethylcarboxamido]-2-carboxy-(1S)-ethylcarboxamido]-3-hydroxy-(2S)-propanoic acid;2-{1-[1-amino-4-amino(imino)methylaminobutylcarboxamidomethylcarboxamido]-2-carboxyethylcarboxamido}-3-hydroxypropanoic acid;3-({2-[(2-Amino-5-carbamimidamido-1-hydroxypentylidene)amino]-1-hydroxyethylidene}amino)-4-[(1-carboxy-2-hydroxyethyl)imino]-4-hydroxybutanoic acid;3-[(S)-2-((S)-2-Amino-5-guanidino-pentanoylamino)-acetylamino]-N-(1-carboxy-2-hydroxy-ethyl)-succinamic acid;3-[2-((S)-2-Amino-5-guanidino-pentanoylamino)-acetylamino]-N-((S)-1-carboxy-2-hydroxy-ethyl)-succinamic acid;3-[2-(2-Amino-5-guanidino-pentanoylamino)-acetylamino]-N-(1-carboxy-2-hydroxy-ethyl)-succinamic acid;3-[2-(2-Amino-5-guanidino-pentanoylamino)-acetylamino]-N-(1-carboxy-2-hydroxy-ethyl)-succinamic acid (RGDS);
Chemical Name:(3S)-3-[[2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-4-[[(1S)-1-carboxy-2-hydroxyethyl]amino]-4-oxobutanoic acid
2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
3. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
5. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More